Shanghai Model Organisms Center 688265.SS · CNY

Its shares trade on Shanghai under the ticker 688265.SS. It has been listed since 28 December 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥421.3m and net income of CN¥32.4m. At that date it held total assets of CN¥1.98bn and shareholders' equity of CN¥1.71bn.

Shanghai Model Organisms Center, Inc. provides life science research and drug discovery services for cancer immunotherapy. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-28. The firm's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Dongxiao FengDeputy General Manager
• Mr. Xuebo ZengDirector
• Mr. Reqing ZhouDirector

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.